3/27
08:02 am
krys
Krystal Biotech (KRYS) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Krystal Biotech (KRYS) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.
3/26
06:13 pm
krys
Krystal Biotech (KRYS) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
Krystal Biotech (KRYS) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
3/17
05:33 pm
krys
Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) [Yahoo! Finance]
Low
Report
Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) [Yahoo! Finance]
3/17
10:18 am
krys
Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight [Yahoo! Finance]
Low
Report
Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight [Yahoo! Finance]
3/13
08:09 am
krys
VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
2/28
02:39 am
krys
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 [Yahoo! Finance]
Medium
Report
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 [Yahoo! Finance]
2/25
09:39 am
krys
Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.
Low
Report
Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.
2/24
08:00 am
krys
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
Low
Report
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
2/24
04:32 am
krys
Krystal Biotech's KB707 RMAT Win Opens New Lung Cancer Chapter [Yahoo! Finance]
Medium
Report
Krystal Biotech's KB707 RMAT Win Opens New Lung Cancer Chapter [Yahoo! Finance]
2/22
01:22 pm
krys
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 [Yahoo! Finance]
Medium
Report
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 [Yahoo! Finance]
2/21
06:44 am
krys
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating [Yahoo! Finance]
Medium
Report
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating [Yahoo! Finance]
2/19
06:47 pm
krys
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
2/18
08:13 am
krys
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $220.00 to $323.00. They now have a "buy" rating on the stock.
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $220.00 to $323.00. They now have a "buy" rating on the stock.
2/18
07:18 am
krys
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/17
04:21 pm
krys
Krystal Biotech Inc (KRYS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
Krystal Biotech Inc (KRYS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
2/17
04:01 pm
krys
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/17
03:56 pm
krys
Krystal Biotech targets global VYJUVEK expansion with Italy launch in H2 2026 while maintaining 90%–95% gross margin outlook [Seeking Alpha]
Low
Report
Krystal Biotech targets global VYJUVEK expansion with Italy launch in H2 2026 while maintaining 90%–95% gross margin outlook [Seeking Alpha]
2/17
03:11 pm
krys
Krystal: Profitable Growth And The Expanding Reach Of HSV-1 Technology [Seeking Alpha]
Low
Report
Krystal: Profitable Growth And The Expanding Reach Of HSV-1 Technology [Seeking Alpha]
2/17
02:05 pm
krys
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Medium
Report
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
2/17
12:46 pm
krys
Krystal Biotech, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Krystal Biotech, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/17
11:01 am
krys
Krystal Biotech Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Krystal Biotech Q4 Earnings Call Highlights [Yahoo! Finance]
2/17
07:00 am
krys
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Medium
Report
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
2/17
02:38 am
krys
Assessing Krystal Biotech (KRYS) Valuation After RMAT Designation For KB707 Immunotherapy Candidate [Yahoo! Finance]
Medium
Report
Assessing Krystal Biotech (KRYS) Valuation After RMAT Designation For KB707 Immunotherapy Candidate [Yahoo! Finance]
2/16
04:35 pm
krys
What Krystal Biotech (KRYS)'s RMAT Status for KB707 Means For Shareholders [Yahoo! Finance]
Medium
Report
What Krystal Biotech (KRYS)'s RMAT Status for KB707 Means For Shareholders [Yahoo! Finance]
2/10
01:46 pm
krys
Krystal Biotech: KB707 Program Bolstered By RMAT And 2nd Half 2026 Update [Seeking Alpha]
Low
Report
Krystal Biotech: KB707 Program Bolstered By RMAT And 2nd Half 2026 Update [Seeking Alpha]